Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.605 USD | +3.59% | +9.97% | +145.95% |
May. 02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+145.95% | 156M | |
+28.38% | 48.16B | |
-0.22% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.85% | 25.59B | |
-22.71% | 18.96B | |
+8.45% | 12.92B | |
+29.75% | 12.03B | |
-1.99% | 11.77B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- HC Wainwright Adjusts Cardiff Oncology's Price Target to $14 From $22, Reiterates Buy Rating